title: Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection.
authors.affiliation: Department of Veterinary Science and Microbiology, University ofArizona, Tucson, USA. mriggs@u.arizona.edu
authors.forename: M W
authors.initials: MW
authors.lastname: Riggs
authors.forename: D A
authors.initials: DA
authors.lastname: Schaefer
authors.forename: S J
authors.initials: SJ
authors.lastname: Kapil
authors.forename: L
authors.initials: L
authors.lastname: Barley-Maloney
authors.forename: L E
authors.initials: LE
authors.lastname: Perryman
authors.forename: M R
authors.initials: MR
authors.lastname: McNeil
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000913:Antibodies, Protozoan / Q000276:immunology / Q000627:therapeutic use*; D003457:Cryptosporidiosis / Q000469:parasitology / Q000628:therapy*; D016785:Cryptosporidium parvum / Q000276:immunology* / Q000378:metabolism; D005260:Female; D007116:Immunization, Passive; D008024:Ligands; D008562:Membrane Glycoproteins; D051379:Mice; D011956:Receptors, Cell Surface / Q000276:immunology* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; C423451:CSL receptor, human; D008024:Ligands; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface